Details for New Drug Application (NDA): 212640
✉ Email this page to a colleague
The generic ingredient in EXSERVAN is riluzole. There are nine drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the riluzole profile page.
Medical Subject Heading (MeSH) Categories for 212640
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | FILM;ORAL | Strength | 50MG | ||||
Approval Date: | Nov 22, 2019 | TE: | RLD: | Yes |
Expired US Patents for NDA 212640
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Aquestive | EXSERVAN | riluzole | FILM;ORAL | 212640-001 | Nov 22, 2019 | ⤷ Try for Free | ⤷ Try for Free |
Aquestive | EXSERVAN | riluzole | FILM;ORAL | 212640-001 | Nov 22, 2019 | ⤷ Try for Free | ⤷ Try for Free |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription